Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles
Hasanzadeh Kafshgari, M, Alnakhli, M, Delalat, B, Apostolou, S, Harding, F J, Mäkilä, E, Salonen, J J, Kuss, B J, Voelcker, N H
Published in Biomaterials science (01.12.2015)
Published in Biomaterials science (01.12.2015)
Get full text
Journal Article
Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications
Kuss, B.J, Eyre, H.J, Lane, S.A, Nancarrow, J.K, Whitmore, S.A, Callen, D.F, Deeley, R.G, Cole, S.P.C, Willman, C.L, Kopecky, K.L, Willman, C.L, Kopecky, Kj, Wolman, S.R, Willman, C.L, Kopecky, Kj, Wolman, S.R
Published in The Lancet (British edition) (18.06.1994)
Published in The Lancet (British edition) (18.06.1994)
Get full text
Journal Article
P669: FIXED‐DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST‐LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 3‐YEAR FOLLOW‐UP FROM THE PHASE 2 CAPTIVATE STUDY FD COHORT
Moreno, C., Wierda, W. G., Barr, P. M., Siddiqi, T., Allan, J. N., Kipps, T. J., Trentin, L., Jacobs, R., Jackson, S., Tedeschi, A., Opat, S., Bannerji, R., Kuss, B. J., Croner, L. J., Szafer‐Glusman, E., Zhou, C., Szoke, A., Dean, J. P., Ghia, P., Tam, C. S.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia
Sulda, M. L., Kuss, B. J., Hall, R. K., Bailey, S., Macardle, P. J.
Published in Internal medicine journal (01.02.2012)
Published in Internal medicine journal (01.02.2012)
Get full text
Journal Article
ARA,a Novel ABC Transporter, Is Located at 16p13.1, Is Deleted in inv(16) Leukemias, and Is Shown To Be Expressed in Primitive Hematopoietic Precursors
Kuss, B.J, O'Neill, G.M, Eyre, H, Doggett, N.A, Callen, D.F, Davey, R.A
Published in Genomics (San Diego, Calif.) (01.08.1998)
Published in Genomics (San Diego, Calif.) (01.08.1998)
Get full text
Journal Article
AN IMPROVED BENEFIT‐RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES
Flinn, I.W., Davids, M.S., Hillmen, P., Montillo, M., Delgado, J., Kuss, B.J., Tam, C.S., Jäger, U., Ghia, P., Stilgenbauer, S., Lustgarten, S., Weaver, D.T., Youssoufian, H., Cymbalista, F.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL
Ghia, P., Flinn, I.W., Lamanna, N., Montillo, M., Illés, Á., Etienne, G., Delgado, J., Kuss, B.J., Tam, C.S., Offner, F., Bosch, F., Davids, M.S., Jäger, U., Cymbalista, F., Weaver, D.T., Lustgarten, S., Youssoufian, H., Stilgenbauer, S.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticlesElectronic supplementary information (ESI) available: SEM and TEM images, IRS study, batch adsorption capacity, adsorption kinetics, human plasma protein adsorption (effects on average hydrodynamic diameter of the NPs), cell proliferation assay, cell apoptosis by annexin V analysis and cellular uptake (Z-stack confocal microscopy). See DOI: 10.1039/c5bm00204d
Hasanzadeh Kafshgari, M, Alnakhli, M, Delalat, B, Apostolou, S, Harding, F. J, Mäkilä, E, Salonen, J. J, Kuss, B. J, Voelcker, N. H
Year of Publication 10.11.2015
Year of Publication 10.11.2015
Get full text
Journal Article
In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: A potential role in neuroblastoma therapy
Kuss, Bryone J., Corbo, Margherita, Lau, Wen Min, Fennell, Dean A., Dean, Nicholas M., Cotter, Finbarr E.
Published in International journal of cancer (01.03.2002)
Published in International journal of cancer (01.03.2002)
Get full text
Journal Article